Next Quarterly Earnings
Thursday, November 5, 2026
CW 45
Pre-Market
In 70 days
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Ligand Pharmaceuticals
Ligand Pharmaceuticals is a biopharmaceutical company that develops and markets innovative medicines. Through its unique licensing model, Ligand focuses on identifying, acquiring, and developing promising therapeutics for treating various diseases. The company strengthens its pipeline and generates revenue through partnerships with leading pharmaceutical companies.
Frequently asked questions
When will Ligand Pharmaceuticals report its next quarterly earnings?
Ligand Pharmaceuticals is scheduled to report its next quarterly earnings on 11/05/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
When did Ligand Pharmaceuticals last report quarterly earnings?
Ligand Pharmaceuticals last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at 2.37 USD.
How does Ligand Pharmaceuticals stock react to earnings?
Across its last 3 earnings reports, Ligand Pharmaceuticals stock moved by ±7.1% on average the following day. The largest reaction was -9.6% on 05/07/2026; 2 of 3 reactions were positive.
How often has Ligand Pharmaceuticals beaten expectations?
Ligand Pharmaceuticals has beaten analyst EPS estimates in 4 of its last 5 evaluated quarters (beat rate: 80%).
How do I add the Ligand Pharmaceuticals earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Stock reaction to earnings
±7.1%
Avg. next-day move
-9.6%
Largest move (05/07/2026)
66.7%
Share of positive reactions
±6.4%
Avg. move after 7 days
Basis: price reactions to the last 3 report dates (close to close).
Estimates vs. results
4/5
Quarters above estimates
80%
Beat rate
+8.7%
Avg. EPS surprise
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
Ligand Pharmaceuticals
Country
🇺🇸
More Financial Information